Close Menu
News JournosNews Journos
  • World
  • U.S. News
  • Business
  • Politics
  • Europe News
  • Finance
  • Turkey Reports
  • Money Watch
  • Health
Editors Picks

Trump and Newsom at Odds Over National Guard Deployment Amid Posse Comitatus Act Concerns in LA

June 8, 2025

Sanders and AOC Criticize Trump, Musk, and Democrats at Western Rallies

March 20, 2025

Trump Proposes Self-Deportation for Immigrants with Future Legal Reentry Possibility

April 10, 2025

Trump Ally Named Interim U.S. Attorney for New Jersey Amid Ongoing Legal Challenges

March 24, 2025

Acosta: Half of Americans Want Truth About Trump

April 18, 2025
Facebook X (Twitter) Instagram
Latest Headlines:
  • Trump’s Tariffs Create Unprecedented Challenges for Bedding CEO
  • Explosive-Loaded Donkey Kills Soldier and Injures Two in Colombia
  • Activist Investor Reduces Stake in Johnson Matthey by 50%
  • Norway Embraces Elon Musk Amidst European Backlash
  • Rachel Brosnahan Discusses Lois Lane Role and Local Superheroes in “Superman”
  • Clashes Erupt Between Protesters and Border Patrol Agents Near Ventura County Farm
  • Trump Proposes 35% Tariffs on Canadian Goods
  • Trump Plans 35% Tariff Increase on Canadian Goods
  • State Department Plans Mass Layoffs of 1,800 Employees
  • Ukrainian Spy Agency Officer Killed in Kyiv Shooting
  • Terrorist Apo’s Video Reveals Password and Manifesto Insights
  • Trump Welcomes Nvidia CEO for White House Discussion
  • Midday Stock Highlights: MP, DAL, KLG, HTZ Stand Out
  • Criticism Mounts Over Plans to Reopen Ani Cathedral as Mosque
  • Trump Commends Liberia’s President for English Proficiency as Native Speaker
  • Prospective Mars Buyers Face Costs Up to $4 Million
  • Missing Australian Surfer Rescued Alive on Island After Extensive Search
  • Trump Official Censures Fed Chief Over Office Renovations Amid Criticism of Interest Rates
  • Ferrero Acquires WK Kellogg for $3.1 Billion
  • Mossad Linked to 2020 Assassination of Iranian Nuclear Scientist
Facebook X (Twitter) Instagram
News JournosNews Journos
Subscribe
Thursday, July 10
  • World
  • U.S. News
  • Business
  • Politics
  • Europe News
  • Finance
  • Turkey Reports
  • Money Watch
  • Health
News JournosNews Journos
You are here: News Journos » Finance » Midday Stock Movers: UNH, BABA, HIMS, CELH
Midday Stock Movers: UNH, BABA, HIMS, CELH

Midday Stock Movers: UNH, BABA, HIMS, CELH

News EditorBy News EditorFebruary 21, 2025 Finance 6 Mins Read

In the latest midday trading session, several companies are making headlines due to significant stock movements following key announcements and earnings reports. Notably, shares of Novo Nordisk experienced a rise after the FDA confirmed the resolution of a prolonged shortage of their weight loss injection and diabetes treatment. Conversely, stocks for Hims & Hers Health plummeted in response to this development. Meanwhile, multiple other companies, including UnitedHealth and Block, faced challenges as they navigated disappointing quarterly results and ongoing investigations.

Article Subheadings
1) Novo Nordisk’s Surge Amid Shortage Resolution
2) Hims & Hers Health Stock Plummets
3) Alibaba Shares Climb on Investor Interest
4) UnitedHealth Faces Investigation Challenges
5) Disappointing Earnings at Block and Other Companies

Novo Nordisk’s Surge Amid Shortage Resolution

Shares of Novo Nordisk spiked by 4.9% after a long-standing issue regarding the shortage of its weight loss treatment, Wegovy, and diabetes medication, Ozempic, was officially declared resolved by the Food and Drug Administration (FDA). This announcement came after more than two years of supply disruptions that have plagued the pharmaceutical industry. The resolution means that patients who rely on these medications can expect a more consistent supply.

The FDA’s statement highlights its commitment to ensuring that essential medications remain available, particularly as the healthcare community increasingly recognizes the importance of managing conditions such as obesity and diabetes. The approval is also indicative of increased manufacturing capabilities and better inventory management by Novo Nordisk, which has been working diligently to resolve these supply issues. The timing is essential as the demand for these products continues to grow amid rising obesity rates in the U.S.

Hims & Hers Health Stock Plummets

Contrarily, shares of Hims & Hers Health, a telehealth company that offers compounded versions of Wegovy and Ozempic, experienced a dramatic decline of 22.9%. This drop can be attributed to the FDA’s announcement regarding the shortage resolution. Hims & Hers had capitalized on the short supply of semaglutide, the active ingredient in these medications, by providing customized treatments through compounding pharmacies.

However, this practice was contingent on the context of the drug shortage. With the FDA’s resolution stating that these medications are no longer considered in short supply, the company is now restricted from selling its compounded versions, which has led to a sharp reconsideration of its market viability. Hims & Hers will continue to have access to its compounding facilities until May 22, providing a temporary buffer but also raising uncertainties about future revenue streams.

Alibaba Shares Climb on Investor Interest

In a positive turn, Alibaba shares surged 5.7%, reaching a new 52-week high. This uptick follows reports that Ryan Cohen, the CEO of GameStop and a prominent billionaire investor, has increased his stake in the Chinese e-commerce giant to approximately $1 billion. Such investment activity has proven favorable for Alibaba, as it suggests renewed confidence in the company’s prospects within the tech and e-commerce sectors.

Analysts speculate that Cohen’s involvement may signal a belief in Alibaba’s potential to recover commercially, especially amid regulatory shifts and market dynamics that have previously hindered its growth. The firm has been focusing on diversifying its offerings and enhancing operational efficiencies, presenting attractive opportunities for investors looking for growth in a volatile market.

UnitedHealth Faces Investigation Challenges

Meanwhile, UnitedHealth shares took an 8.6% hit after reports surfaced that the company is under investigation by the Justice Department. This investigation centers around UnitedHealth’s practices for recording diagnoses that could lead to increased payments under their Medicare Advantage plans. The implications of such scrutiny are significant as the company navigates a complex regulatory landscape.

In response to the allegations, UnitedHealth has firmly denied any wrongdoing, labeling the insinuation of fraudulent practices as “outrageous and false.” Despite this declaration, the negative impact on stock prices reflects market concerns about how prolonged investigations can disrupt corporate operations and investor confidence. UnitedHealth’s stock has now depreciated more than 20% in the past three months, reflecting broader sentiments regarding potential financial and reputational repercussions.

Disappointing Earnings at Block and Other Companies

Additionally, shares of Block declined by 17.2% after the firm reported disappointing quarterly earnings and revenue that fell short of analyst expectations. Block disclosed adjusted earnings of 71 cents per share on $6.03 billion in revenue, while analysts predicted earnings of 87 cents per share alongside revenue expectations of $6.29 billion. Such discrepancies raise questions about the fintech company’s growth strategies and market position.

Shares of Dropbox also faced challenges, losing about 13.8% on mixed earnings results, demonstrating the volatility within the tech sector. Although the company reported an impressive non-GAAP gross margin of 83.1%, concerns arose as it could not fully meet overall expectations in terms of adjusted earnings. Other companies like Akamai Technologies and Insulet saw stock price dips due to weaker-than-anticipated future guidance, indicating a broader hesitance within the tech and pharmaceutical industries.

No. Key Points
1 Novo Nordisk’s stock rose significantly following the resolution of a two-year shortage of its medications.
2 Hims & Hers Health saw its stock plummet due to the FDA’s announcement regarding the availability of brand name medications.
3 Alibaba’s shares surged as investor confidence grew after a prominent billionaire increased his stake in the company.
4 UnitedHealth’s stock dropped following news of a Justice Department investigation into its Medicare Advantage practices.
5 Block and Dropbox reported disappointing earnings, leading to substantial declines in their stock prices.

Summary

The midday trading session has highlighted the volatility of the stock market as major companies react to regulatory changes and earnings reports. While Novo Nordisk stands to benefit from an FDA resolution, Hims & Hers Health faces uncertain futures. Furthermore, the performance of Alibaba reflects positive investor sentiment, while UnitedHealth grapples with investigative scrutiny. The mixed outcomes for Block and Dropbox signal challenges within the tech sector, emphasizing the complex landscape companies must navigate in order to maintain investor trust and market stability.

Frequently Asked Questions

Question: What factors led to the rise in Novo Nordisk’s stock price?

The rise in Novo Nordisk’s stock price is primarily due to the FDA announcing the resolution of a prolonged shortage of its key medications, Wegovy and Ozempic, improving market confidence in the company’s supply stability.

Question: Why did Hims & Hers Health’s stock decline so sharply?

Hims & Hers Health’s stock decline is linked to the FDA’s declaration of the resolution of the semaglutide shortage, which diminishes the company’s ability to sell compounded versions of the medication, affecting its revenue model.

Question: What are the implications of UnitedHealth’s investigation?

The implications of UnitedHealth’s investigation include potential regulatory impacts and scrutiny over its billing practices, which could lead to a loss of market confidence and affect its stock performance in the long term.

BABA Bonds Budgeting CELH Credit Scores Cryptocurrency Debt Management Economic Policy Financial Literacy Financial Markets Financial Planning Forex Trading Hims Investing midday Movers Mutual Funds Personal Finance Portfolio Management Real Estate Investing Retirement Planning Savings Stock Stock Market Tax Strategies UNH Wealth Management
Share. Facebook Twitter Pinterest LinkedIn Email Reddit WhatsApp Copy Link Bluesky
News Editor
  • Website

As the News Editor at News Journos, I am dedicated to curating and delivering the latest and most impactful stories across business, finance, politics, technology, and global affairs. With a commitment to journalistic integrity, we provide breaking news, in-depth analysis, and expert insights to keep our readers informed in an ever-changing world. News Journos is your go-to independent news source, ensuring fast, accurate, and reliable reporting on the topics that matter most.

Keep Reading

Finance

Midday Stock Highlights: MP, DAL, KLG, HTZ Stand Out

5 Mins Read
Finance

Federal Reserve Explores New Standards for ‘Well-Managed’ Banks

6 Mins Read
Finance

Trump’s Proposal Removes $7,500 EV Tax Credit

6 Mins Read
Finance

Vanguard and BlackRock Unveil Strategies for Second Half of 2025

6 Mins Read
Finance

Tech Giants Gather at Exclusive Summer Retreat for Billionaires

5 Mins Read
Finance

Premarket Stock Movers: SBUX, AES, VRNA, UNH

6 Mins Read
Mr Serdar Avatar

Serdar Imren

News Director

Facebook Twitter Instagram
Journalism Under Siege
Editors Picks

Trump Announces Major Trade Deal with Key Ally Amidst Other Top Headlines

May 8, 2025

Jewish Tesla Owner Shocked by Activist Drawing Swastika on Cybertruck

March 16, 2025

U.S. Closes Southern Border to Livestock Imports to Combat Deadly Fly Outbreak

May 11, 2025

Hollywood Honors Conan O’Brien Amid Kennedy Center Changes, Takes Aim at Trump

March 23, 2025

GOP Authorizes Trump to Use Military Force Against Cartels

March 24, 2025

Subscribe to News

Get the latest sports news from NewsSite about world, sports and politics.

Facebook X (Twitter) Pinterest Vimeo WhatsApp TikTok Instagram

News

  • World
  • U.S. News
  • Business
  • Politics
  • Europe News
  • Finance
  • Money Watch

Journos

  • Top Stories
  • Turkey Reports
  • Health
  • Tech
  • Sports
  • Entertainment

COMPANY

  • About Us
  • Get In Touch
  • Our Authors
  • Privacy Policy
  • Terms and Conditions
  • Accessibility

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

© 2025 The News Journos. Designed by The News Journos.

Type above and press Enter to search. Press Esc to cancel.

Ad Blocker Enabled!
Ad Blocker Enabled!
Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.